Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin.

Navarro V, Martin S, Sarret P, Nielsen MS, Petersen CM, Vincent J, Mazella J.

FEBS Lett. 2001 Apr 20;495(1-2):100-5.

2.

Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line.

Martin S, Navarro V, Vincent JP, Mazella J.

Gastroenterology. 2002 Oct;123(4):1135-43.

PMID:
12360476
3.

Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells.

Morinville A, Martin S, Lavallée M, Vincent JP, Beaudet A, Mazella J.

Int J Biochem Cell Biol. 2004 Nov;36(11):2153-68.

PMID:
15313463
4.
5.

Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line.

Navarro V, Vincent JP, Mazella J.

Biochem Biophys Res Commun. 2002 Nov 15;298(5):760-4.

PMID:
12419319
6.
7.
8.

Internalization and recycling properties of neurotensin receptors.

Mazella J, Vincent JP.

Peptides. 2006 Oct;27(10):2488-92. Epub 2006 Aug 9. Review.

PMID:
16901585
9.

Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor.

Vandenbulcke F, Nouel D, Vincent JP, Mazella J, Beaudet A.

J Cell Sci. 2000 Sep;113 ( Pt 17):2963-75.

10.

Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding.

Munck Petersen C, Nielsen MS, Jacobsen C, Tauris J, Jacobsen L, Gliemann J, Moestrup SK, Madsen P.

EMBO J. 1999 Feb 1;18(3):595-604.

11.

Cell-type-specific pathways of neurotensin endocytosis.

Savdie C, Ferguson SS, Vincent J, Beaudet A, Stroh T.

Cell Tissue Res. 2006 Apr;324(1):69-85. Epub 2005 Dec 23.

PMID:
16374621
12.

Expression of the 100-kDa neurotensin receptor sortilin during mouse embryonal development.

Hermans-Borgmeyer I, Hermey G, Nykjaer A, Schaller C.

Brain Res Mol Brain Res. 1999 Mar 5;65(2):216-9.

PMID:
10064893
13.

The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor.

Mazella J, Zsürger N, Navarro V, Chabry J, Kaghad M, Caput D, Ferrara P, Vita N, Gully D, Maffrand JP, Vincent JP.

J Biol Chem. 1998 Oct 9;273(41):26273-6.

14.

Thr-422 and Tyr-424 residues in the carboxyl terminus are critical for the internalization of the rat neurotensin receptor.

Chabry J, Botto JM, Nouel D, Beaudet A, Vincent JP, Mazella J.

J Biol Chem. 1995 Feb 10;270(6):2439-42.

15.

Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase.

Nielsen MS, Jacobsen C, Olivecrona G, Gliemann J, Petersen CM.

J Biol Chem. 1999 Mar 26;274(13):8832-6.

16.

[Neurotensin: reception and intracellular mechanisms of signaling].

Osadchiĭ OE.

Usp Fiziol Nauk. 2006 Apr-Jun;37(2):52-70. Review. Russian.

PMID:
16758885
17.

Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system.

Sarret P, Krzywkowski P, Segal L, Nielsen MS, Petersen CM, Mazella J, Stroh T, Beaudet A.

J Comp Neurol. 2003 Jul 7;461(4):483-505.

PMID:
12746864
18.
19.

The N-terminal neurotensin fragment, NT1-11, inhibits cortisol secretion by human adrenocortical cells.

Sicard F, Contesse V, Lefebvre H, Ait-Ali D, Gras M, Cartier D, Decker A, Chartrel N, Anouar Y, Vaudry H, Delarue C.

J Clin Endocrinol Metab. 2006 Aug;91(8):3131-7. Epub 2006 May 16.

PMID:
16705076
20.

Identification in the rat neurotensin receptor of amino-acid residues critical for the binding of neurotensin.

Botto JM, Chabry J, Nouel D, Paquet M, Séguéla P, Vincent JP, Beaudet A, Mazella J.

Brain Res Mol Brain Res. 1997 Jun;46(1-2):311-7.

PMID:
9191107

Supplemental Content

Support Center